Ads
related to: exogenous surfactant therapy for anxiety
Search results
Results from the WOW.Com Content Network
Surfactant therapy is the medical administration of pulmonary surfactant that is derived from outside of the body. Pulmonary surfactant is a soap-like chemical synthesized by type II alveolar pneumocytes and is of various lipids (80% phospholipids, 5-10% cholesterol, and ∼10% surfactant-associated proteins).
Systematic desensitization, or graduated exposure therapy, is a behavior therapy developed by the psychiatrist Joseph Wolpe. It is used when a phobia or anxiety disorder is maintained by classical conditioning .
Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. [ 1 ] Prevention is generally done in babies born at a gestational age of less than 32 weeks. [ 1 ]
Exposure therapy is a technique in behavior therapy to treat anxiety disorders. Exposure therapy involves exposing the patient to the anxiety source or its context (without the intention to cause any danger). Doing so is thought to help them overcome their anxiety or distress.
Tofisopam [3] (Emandaxin, Grandaxin, Sériel) is an anxiolytic that is marketed in several European countries. [4] Chemically, it is a 2,3-benzodiazepine. Unlike other anxiolytic benzodiazepines (which are generally 1,4- or 1,5-substituted) however, tofisopam does not have anticonvulsant, sedative, [5] skeletal muscle relaxant, motor skill-impairing or amnestic [6] properties.
Homeownership has long been known as a tool for building wealth and lifting Americans into the middle class. But a new report highlights other ways in which renting burdens many households ...
Ads
related to: exogenous surfactant therapy for anxiety